HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine M Ambler Selected Research

PF-04445597

7/2014Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine M Ambler Research Topics

Disease

1Rheumatoid Arthritis
10/2018
1Autoimmune Diseases (Autoimmune Disease)
10/2018
1Psoriatic Arthritis
10/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2018
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2018
1Carcinoma (Carcinomatosis)
07/2014
1Coronary Disease (Coronary Heart Disease)
07/2014
1Breast Neoplasms (Breast Cancer)
11/2010

Drug/Important Bio-Agent (IBA)

1CytokinesIBA
10/2018
1Monoclonal AntibodiesIBA
10/2018
1Cholesterol Ester Transfer ProteinsIBA
07/2014
1AldosteroneIBA
07/2014
1HDL CholesterolIBA
07/2014
1PF-04445597IBA
07/2014
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2010
1Proteins (Proteins, Gene)FDA Link
11/2010